265 related articles for article (PubMed ID: 34264124)
21. Honokiol crosses BBB and BCSFB, and inhibits brain tumor growth in rat 9L intracerebral gliosarcoma model and human U251 xenograft glioma model.
Wang X; Duan X; Yang G; Zhang X; Deng L; Zheng H; Deng C; Wen J; Wang N; Peng C; Zhao X; Wei Y; Chen L
PLoS One; 2011 Apr; 6(4):e18490. PubMed ID: 21559510
[TBL] [Abstract][Full Text] [Related]
22. Creatine and guanidinoacetate transport at blood-brain and blood-cerebrospinal fluid barriers.
Braissant O
J Inherit Metab Dis; 2012 Jul; 35(4):655-64. PubMed ID: 22252611
[TBL] [Abstract][Full Text] [Related]
23. Capture, crawl, cross: the T cell code to breach the blood-brain barriers.
Engelhardt B; Ransohoff RM
Trends Immunol; 2012 Dec; 33(12):579-89. PubMed ID: 22926201
[TBL] [Abstract][Full Text] [Related]
24. Application of contrast-enhanced magnetic resonance imaging in the assessment of blood-cerebrospinal fluid barrier integrity.
Verheggen ICM; Freeze WM; de Jong JJA; Jansen JFA; Postma AA; van Boxtel MPJ; Verhey FRJ; Backes WH
Neurosci Biobehav Rev; 2021 Aug; 127():171-183. PubMed ID: 33930471
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of blood-brain barrier and blood-cerebrospinal fluid barrier permeability of 2-phenoxy-indan-1-one derivatives using in vitro cell models.
Hu HH; Bian YC; Liu Y; Sheng R; Jiang HD; Yu LS; Hu YZ; Zeng S
Int J Pharm; 2014 Jan; 460(1-2):101-7. PubMed ID: 24262988
[TBL] [Abstract][Full Text] [Related]
26. Pharmacological significance of prostaglandin E2 and D2 transport at the brain barriers.
Tachikawa M; Hosoya K; Terasaki T
Adv Pharmacol; 2014; 71():337-60. PubMed ID: 25307222
[TBL] [Abstract][Full Text] [Related]
27. Central Nervous System Stimulants Limit Caffeine Transport at the Blood-Cerebrospinal Fluid Barrier.
Ikeda-Murakami K; Tani N; Ikeda T; Aoki Y; Ishikawa T
Int J Mol Sci; 2022 Feb; 23(3):. PubMed ID: 35163784
[TBL] [Abstract][Full Text] [Related]
28. Blood-brain barrier in chronic relapsing experimental allergic encephalomyelitis: a correlative study between cerebrospinal fluid protein concentrations and tracer leakage in the central nervous system.
Kitz K; Lassmann H; Karcher D; Lowenthal A
Acta Neuropathol; 1984; 63(1):41-50. PubMed ID: 6730912
[TBL] [Abstract][Full Text] [Related]
29. Quantification of Transporter and Receptor Proteins in Dog Brain Capillaries and Choroid Plexus: Relevance for the Distribution in Brain and CSF of Selected BCRP and P-gp Substrates.
Braun C; Sakamoto A; Fuchs H; Ishiguro N; Suzuki S; Cui Y; Klinder K; Watanabe M; Terasaki T; Sauer A
Mol Pharm; 2017 Oct; 14(10):3436-3447. PubMed ID: 28880093
[TBL] [Abstract][Full Text] [Related]
30. Potential Pathways for CNS Drug Delivery Across the Blood-Cerebrospinal Fluid Barrier.
Strazielle N; Ghersi-Egea JF
Curr Pharm Des; 2016; 22(35):5463-5476. PubMed ID: 27464721
[TBL] [Abstract][Full Text] [Related]
31. Magnetic resonance imaging with upconversion nanoprobes capable of crossing the blood-cerebrospinal fluid barrier.
Han F; Gao J; Lv G; Liu T; Hu Q; Zhu M; Du Z; Yang J; Yao Z; Fang X; Ni D; Zhang J
J Nanobiotechnology; 2024 Jan; 22(1):43. PubMed ID: 38287357
[TBL] [Abstract][Full Text] [Related]
32. Changes in the choroid plexuses and brain barriers associated with high blood pressure and ageing.
Gonzalez-Marrero I; Hernández-Abad LG; Castañeyra-Ruiz L; Carmona-Calero EM; Castañeyra-Perdomo A
Neurologia (Engl Ed); 2022 Jun; 37(5):371-382. PubMed ID: 30060976
[TBL] [Abstract][Full Text] [Related]
33. Facilitating drug delivery in the central nervous system by opening the blood-cerebrospinal fluid barrier with a single low energy shockwave pulse.
Kung Y; Chen KY; Liao WH; Hsu YH; Wu CH; Hsiao MY; Huang AP; Chen WS
Fluids Barriers CNS; 2022 Jan; 19(1):3. PubMed ID: 34991647
[TBL] [Abstract][Full Text] [Related]
34. Development of a permeability-limited model of the human brain and cerebrospinal fluid (CSF) to integrate known physiological and biological knowledge: Estimating time varying CSF drug concentrations and their variability using in vitro data.
Gaohua L; Neuhoff S; Johnson TN; Rostami-Hodjegan A; Jamei M
Drug Metab Pharmacokinet; 2016 Jun; 31(3):224-33. PubMed ID: 27236639
[TBL] [Abstract][Full Text] [Related]
35. Blood-Cerebrospinal Fluid Barrier Gradients in Mild Cognitive Impairment and Alzheimer's Disease: Relationship to Inflammatory Cytokines and Chemokines.
Ott BR; Jones RN; Daiello LA; de la Monte SM; Stopa EG; Johanson CE; Denby C; Grammas P
Front Aging Neurosci; 2018; 10():245. PubMed ID: 30186149
[No Abstract] [Full Text] [Related]
36. Tight junctions in brain barriers during central nervous system inflammation.
Coisne C; Engelhardt B
Antioxid Redox Signal; 2011 Sep; 15(5):1285-303. PubMed ID: 21338320
[TBL] [Abstract][Full Text] [Related]
37. Distributed model analysis of 3'-azido-3'-deoxythymidine and 2',3'-dideoxyinosine distribution in brain tissue and cerebrospinal fluid.
Takasawa K; Terasaki T; Suzuki H; Ooie T; Sugiyama Y
J Pharmacol Exp Ther; 1997 Sep; 282(3):1509-17. PubMed ID: 9316866
[TBL] [Abstract][Full Text] [Related]
38. Mechanisms of neuropsychiatric lupus: The relative roles of the blood-cerebrospinal fluid barrier versus blood-brain barrier.
Gelb S; Stock AD; Anzi S; Putterman C; Ben-Zvi A
J Autoimmun; 2018 Jul; 91():34-44. PubMed ID: 29627289
[TBL] [Abstract][Full Text] [Related]
39. Amyloid β Oligomers Disrupt Blood-CSF Barrier Integrity by Activating Matrix Metalloproteinases.
Brkic M; Balusu S; Van Wonterghem E; Gorlé N; Benilova I; Kremer A; Van Hove I; Moons L; De Strooper B; Kanazir S; Libert C; Vandenbroucke RE
J Neurosci; 2015 Sep; 35(37):12766-78. PubMed ID: 26377465
[TBL] [Abstract][Full Text] [Related]
40. Blood-arachnoid barrier disruption in experimental rat meningitis detected using gadolinium-enhancement ratio imaging.
Ichikawa H; Itoh K
Brain Res; 2011 May; 1390():142-9. PubMed ID: 21435335
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
